The Cerebro Mainframe is a governed clinical decision-support SaMD for structured signal capture, pattern detection, and clinician review—across brain and metabolic health.
Cerebro is in an experimental research phase, onboarding a limited number of clinical sites and research partners to evaluate governed AI decision support workflows across brain and metabolic health. If you’re exploring structured signal capture and clinician review in real-world settings, initiate contact to discuss fit, governance, and timelines.
Investigational system. Not FDA cleared or evaluated. Not available for public sale. For research and evaluation use
Cerebro NeuroTech, Inc. is an AI medical software company, venture-backed and supported by Techstars, Prosper HealthTech Accelerator, and 450 Ventures (BCBSAL’s corporate venture fund).
Excerpt: AI Model Data Flow
Open research. Structured development. Clinical intent.
CRu Open Modules is where Cerebro shares the scientific foundations, experimental modules, and translational pathways that inform our clinical AI systems.